Ascentia is a science-driven biotechnology company and integrated CRO partner, specializing in the discovery and development of small-molecule therapeutics.
As a contract research organization, we collaborate with biotech, pharma, and academic teams by offering flexible, end-to-end support in medicinal chemistry (including computer-aided drug design), synthetic chemistry,biology, biochemistry and biophysics.
Our internal R&D concentrates on underexplored areas of biology, with a special focus on modulation of transmembrane receptors that provide novel opportunities for therapeutic intervention.
Whether advancing internal pipelines or supporting client programs, Ascentia delivers high-impact solutions tailored to modern R&D sector requirements.
Company Details
- Employees
- 6
- Founded
- 2024
- Address
- Ul. Dubois, 114/116,poland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ascentiabio.com/pl/
- Keywords
- Medicinal Chemistry, Drug Discovery, Contract Research Organization, Small Molecules Supply, Biology, Biotechnology.
- HQ
- Łódź, Łódź Voivodeship
Ascentia Questions
Ascentia's website is https://ascentiabio.com/pl/
Ascentia's LinkedIn profile is https://pl.linkedin.com/company/ascentiabio
Ascentia has
6 employees.
View email and phone details for 6
employees at Ascentia.
Ascentia's industry is
Biotechnology Research
Ascentia's top competitors are
Biorenomé,
Adamed Pharma,
Fileclo,
Ascentia Organisation,
Ascentia Uae,
Syvento Biotech,
Poltreg S.a.,
Trimen Chemicals Sp. Z O.o.,
Molecure,
Captor Therapeutics Sa.
Ascentia's categories are Biotechnology Research
Ascentia's founding year is 2024
